-0.10%
Today
Loading 1D prices…
Company profile
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
Jerusalem, Israel, United States
Employees
121
Fiscal year end
1231
CIK
1871321
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| KMTSKestra Medical Technologies Ltd. Common Stock | $1.3B | $95.1M | -138.36% | -$2.43 | -3.05% | Buy |
| AORTArtivion Inc. Common Stock | $1.2B | $441.3M | +2.21% | $0.21 | +1.70% | Buy |
| IARTIntegra LifeSciences Holdings Corporation Common Stock | $1.2B | $1.6B | -31.60% | -$6.74 | -0.26% | Hold |
| TNDMTandem Diabetes Care Inc. Common Stock | $1.2B | $1B | -20.17% | -$3.04 | -6.66% | Buy |
| PRCTPROCEPT BioRobotics Corporation Common Stock | $1.2B | $308.1M | -0.03% | -$1.72 | +1.49% | Hold |